Combining clonidine and nicotine replacement for treatment of nicotine withdrawal
- PMID: 2681633
- DOI: 10.1080/02791072.1989.10472177
Combining clonidine and nicotine replacement for treatment of nicotine withdrawal
Abstract
The U.S. Surgeon General's 1988 report on nicotine addiction has increased the need for the substance abuse treatment community to become more involved in smoking cessation programs. A unique approach to nicotine detoxification has been developed at the Haight Ashbury Free Clinics' Drug Detoxification, Rehabilitation and Aftercare Project. After an evaluation by a physician, a thorough explanation of the treatment plan, and if the patient is interested, a combination of clonidine via the transdermal patch (Catapres-TTS) and of nicotine replacement via nicotine polacrilex (Nicorette) is used. By combining a Nicorette taper with clonidine, the physician can control the rate of nicotine withdrawal (Nicorette) and the extent to which withdrawal symptoms are treated (clonidine). This appears to be an effective, comfortable method for detoxification from cigarettes and nicotine. Its use should prove helpful as an adjunct to a comprehensive smoking cessation program.
Similar articles
-
Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.Arch Intern Med. 1992 Oct;152(10):2065-9. Arch Intern Med. 1992. PMID: 1417380 Clinical Trial.
-
Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.Arch Intern Med. 1988 Sep;148(9):2027-31. Arch Intern Med. 1988. PMID: 3046542 Clinical Trial.
-
[Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation].Arch Inst Cardiol Mex. 1992 Sep-Oct;62(5):435-40. Arch Inst Cardiol Mex. 1992. PMID: 1482222 Clinical Trial. Spanish.
-
Pharmacotherapy for smoking cessation.Clin Pharm. 1989 Oct;8(10):710-20. Clin Pharm. 1989. PMID: 2680239 Review.
-
Nicotine, corticotropin, and smoking withdrawal symptoms: literature review and implications for successful control of nicotine addiction.Clin Ther. 1989 Nov-Dec;11(6):846-53. Clin Ther. 1989. PMID: 2558798 Review.
Cited by
-
Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?J Med Toxicol. 2014 Dec;10(4):369-81. doi: 10.1007/s13181-014-0430-3. J Med Toxicol. 2014. PMID: 25238670 Free PMC article. Review.
-
Cigarette smoking, nicotine dependence, and treatment.West J Med. 1990 May;152(5):578-84. West J Med. 1990. PMID: 2190425 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources